H. Río Carrión
About H. Río Carrión
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ALK-Abelló A/S
1
Adacyte Therapeutics SL
1
Boehringer Ingelheim
1
Hospital Universitario Getafe
1
Laboratorios Leti, S.L.
1
PETHEMA Foundation
1
Spanish Breast Cancer Research Group
1
Clinical Trials at H. Río Carrión
During the past decade, H. Río Carrión conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
2008-06-01
2013-10-01
Completed
153
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
2011-06-01
2012-04-01
Completed
199
This Study Observes the Usage of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) in Elderly Patients With a Heart Rhythm Disorder in Spain
2019-07-30
2020-08-20
Completed
500
Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
2019-11-25
2027-02-01
Recruiting
300
National GMA Post-market Clinical Follow-up Study (GRACE)
2022-01-11
2025-12-31
Recruiting
350
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "H. Río Carrión" #1 sponsor was "ALK-Abelló A/S" with 1 trials, followed by "Adacyte Therapeutics SL" with 1 trials
sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Hospital Universitario Getafe" with 1 trials sponsored and "Laboratorios Leti, S.L."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "H. Río Carrión"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at H. Río Carrión
According to Clinical.Site data, the most researched conditions in "H. Río Carrión" are
"Acute Lymphoblastic Leukemia" (1 trials), "Acute Respiratory Failure" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "H. Río Carrión" in a lesser frequency.
Clinical Trials Intervention Types at H. Río Carrión
Most popular intervention types in "H. Río Carrión" are "Drug" (4 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "AVANZ Phleum pratense" (1 trials), "Adacolumn" (1 trials), "Allergen extract (Phleum pratense)" (1 trials), "Cyclophosphamide" (1 trials) and "Epirubicin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at H. Río Carrión
The vast majority of trials in "H. Río Carrión" are
6 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at H. Río Carrión
Currently, there are NaN active trials in "H. Río Carrión".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in H. Río Carrión,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in H. Río Carrión, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".